MCQs Quiz

Investigational New Drug (IND) application procedure is a key regulatory pathway that allows new pharmaceuticals to move from laboratory research into human clinical trials. This introduction covers essential concepts B.Pharm students must master: IND submission components, CMC (chemistry, manufacturing and controls), nonclinical toxicology, GLP and GMP requirements, safety reporting, sponsor and investigator responsibilities, protocol amendments, … Read more

Overview of regulatory approval processes MCQs With Answer — Introduction This concise overview for B. Pharm students covers regulatory approval processes, explaining regulatory authorities (FDA, EMA, CDSCO), drug development stages, clinical trial phases, dossier formats (CTD/eCTD), NDA and ANDA submissions, bioequivalence, Good Manufacturing Practices (GMP), pharmacovigilance, stability studies, and post-marketing surveillance. Emphasis on regulatory guidelines … Read more

Concept and development of generic drug products is a core topic for B. Pharm students covering how pharmaceutically equivalent medicines are formulated, tested, and approved for market entry. This introduction explores key concepts: generic drug definition, regulatory pathways like ANDA, reference-listed drug (RLD), bioequivalence (BE) study design, therapeutic equivalence, formulation and excipient considerations, dissolution testing, … Read more

Understanding the difference between innovator and generic drugs is essential for B. Pharm students preparing for pharmacy practice and regulatory roles. This concise, keyword-rich introduction highlights innovator drug, generic drug, bioequivalence, ANDA, patent protection, therapeutic equivalence, excipients, formulation differences, stability, and regulatory approval pathways. Learn how innovator products result from discovery, clinical trials and data … Read more

Clinical development phases I–IV overview MCQs With Answer provides B.Pharm students a clear, practical guide to drug development stages, from first-in-human trials to post-marketing surveillance. This concise introduction emphasizes key concepts: Phase I safety and pharmacokinetics, Phase II dose-finding and preliminary efficacy, Phase III large randomized controlled trials for definitive efficacy and safety, and Phase … Read more

Non-clinical evaluation and safety testing are essential preclinical steps that assess a drug’s toxicity, pharmacokinetics, and biological effects before human trials. For B. Pharm students, understanding study types—acute, subchronic, chronic, genotoxicity, carcinogenicity, reproductive toxicity, safety pharmacology—and guidelines such as GLP, OECD and ICH is vital. Learn about endpoints like LD50, NOAEL, MTD, ADME profiling, in … Read more

Pre-clinical studies form the foundation of drug development by defining safety, pharmacokinetics, toxicity profiles and practical requirements needed before human trials. This concise introduction covers pre-clinical study requirements and objectives, including GLP compliance, animal model selection, dose-range finding, acute/sub-chronic/chronic toxicity, reproductive and genotoxicity testing, safety pharmacology and ADME studies. B.Pharm students will learn how to … Read more

Drug development phases and workflow MCQs With Answer Understanding drug development phases and workflow is essential for B.Pharm students preparing for careers in pharmaceutical research, clinical trials, regulatory affairs and quality control. This introduction covers key concepts such as preclinical studies, IND/NDA submissions, clinical phases I–IV, ADME, pharmacokinetics/pharmacodynamics (PK/PD), GLP/GMP/GCP compliance, toxicology (NOAEL, MTD), CMC … Read more

Introduction: The stages of drug discovery outline the systematic drug discovery process from target identification to clinical trials and regulatory approval. For B.Pharm students, understanding target identification, target validation, hit identification, hit-to-lead, lead optimization, ADMET assessment, preclinical studies and clinical trials is essential. Emphasis on structure-based design, high-throughput screening, SAR, pharmacokinetics, toxicology and regulatory submissions … Read more

Introduction: The National Pharmaceutical Pricing Authority (NPPA) is the statutory body responsible for drug price regulation and monitoring in India. NPPA implements the Drug Price Control Order (DPCO), fixes ceiling prices for scheduled formulations, monitors market prices, and ensures affordability and availability of essential medicines. Key functions include price fixation, enforcement against overcharging, periodic price … Read more